U-Blot® Research Grade inclocibartCat. No. WA2980$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade inclocibartCat. No. WA2980
U-Blot® Research Grade InclacumabCat. No. WA2979
U-Blot® Research Grade InbakiceptCat. No. WA2978
U-Blot® Research Grade imzokitugCat. No. WA2977
U-Blot® Research Grade ImvotamabCat. No. WA2976
U-Blot® Research Grade ImsidolimabCat. No. WA2975
U-Blot® Research Grade imneskibartCat. No. WA2974
U-Blot® Research Grade Immurait-Ll2MabCat. No. WA2973
U-Blot® Research Grade ImgatuzumabCat. No. WA2972
U-Blot® Research Grade imeroprubartCat. No. WA2971
U-Blot® Research Grade ImelcimentCat. No. WA2970
U-Blot® Research Grade ImdevimabCat. No. WA2969